
Robert A. Zeman
Examiner (ID: 6698, Phone: (571)272-0866 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1643 |
| Total Applications | 1323 |
| Issued Applications | 556 |
| Pending Applications | 271 |
| Abandoned Applications | 535 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18953427
[patent_doc_number] => 20240041754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => NOVEL SACCHAROMYCES CEREVISIAE STRAIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/258841
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258841
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258841 | NOVEL SACCHAROMYCES CEREVISIAE STRAIN AND USE THEREOF | Dec 22, 2021 | Pending |
Array
(
[id] => 17748242
[patent_doc_number] => 20220226445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
[patent_app_type] => utility
[patent_app_number] => 17/558418
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558418 | CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO | Dec 20, 2021 | Abandoned |
Array
(
[id] => 17519321
[patent_doc_number] => 20220105169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/554354
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554354 | PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS | Dec 16, 2021 | Abandoned |
Array
(
[id] => 19098070
[patent_doc_number] => 20240117298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => MICROORGANISM THAT PRODUCES USEFUL SUBSTANCE AND METHOD FOR PRODUCING USEFUL SUBSTANCE
[patent_app_type] => utility
[patent_app_number] => 18/266625
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266625
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266625 | MICROORGANISM THAT PRODUCES USEFUL SUBSTANCE AND METHOD FOR PRODUCING USEFUL SUBSTANCE | Dec 15, 2021 | Pending |
Array
(
[id] => 19098070
[patent_doc_number] => 20240117298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => MICROORGANISM THAT PRODUCES USEFUL SUBSTANCE AND METHOD FOR PRODUCING USEFUL SUBSTANCE
[patent_app_type] => utility
[patent_app_number] => 18/266625
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266625
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266625 | MICROORGANISM THAT PRODUCES USEFUL SUBSTANCE AND METHOD FOR PRODUCING USEFUL SUBSTANCE | Dec 15, 2021 | Pending |
Array
(
[id] => 18986427
[patent_doc_number] => 20240058396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => NOVEL STRAIN OF Bifidobacterium animalis subsp. lactis HEM20-01 AND COMPOSITION FOR treating depression, COMPRISING the same OR its culture fluid
[patent_app_type] => utility
[patent_app_number] => 18/259441
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259441
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259441 | NOVEL STRAIN OF Bifidobacterium animalis subsp. lactis HEM20-01 AND COMPOSITION FOR treating depression, COMPRISING the same OR its culture fluid | Dec 13, 2021 | Issued |
Array
(
[id] => 19075314
[patent_doc_number] => 11944657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Agent for inducing interferon production containing lactic acid bacteria
[patent_app_type] => utility
[patent_app_number] => 17/548904
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 51
[patent_no_of_words] => 13837
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17548904
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/548904 | Agent for inducing interferon production containing lactic acid bacteria | Dec 12, 2021 | Issued |
Array
(
[id] => 17642238
[patent_doc_number] => 20220169976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => PROBIOTIC BIFIDOBACTERIUM STRAIN
[patent_app_type] => utility
[patent_app_number] => 17/545148
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17545148
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/545148 | PROBIOTIC BIFIDOBACTERIUM STRAIN | Dec 7, 2021 | Abandoned |
Array
(
[id] => 18019074
[patent_doc_number] => 20220370573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => DERMAL FILLER
[patent_app_type] => utility
[patent_app_number] => 17/541546
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541546
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/541546 | DERMAL FILLER | Dec 2, 2021 | Abandoned |
Array
(
[id] => 18903951
[patent_doc_number] => 20240019436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 18/038901
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038901
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/038901 | BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS | Nov 23, 2021 | Pending |
Array
(
[id] => 17460272
[patent_doc_number] => 20220073577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/533320
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533320
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533320 | Anti-inflammatory compounds and methods of use | Nov 22, 2021 | Issued |
Array
(
[id] => 19226709
[patent_doc_number] => 12006342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Proteins and nucleic acids useful in vaccines targeting
[patent_app_type] => utility
[patent_app_number] => 17/532034
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 72156
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532034
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532034 | Proteins and nucleic acids useful in vaccines targeting | Nov 21, 2021 | Issued |
Array
(
[id] => 18862236
[patent_doc_number] => 20230416672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => Rhodococcus qingshengii bacterial strain that degrades imazethapyr and stimulates crop growth
[patent_app_type] => utility
[patent_app_number] => 18/038010
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/038010 | Rhodococcus qingshengii bacterial strain that degrades imazethapyr and stimulates crop growth | Nov 14, 2021 | Pending |
Array
(
[id] => 18862236
[patent_doc_number] => 20230416672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => Rhodococcus qingshengii bacterial strain that degrades imazethapyr and stimulates crop growth
[patent_app_type] => utility
[patent_app_number] => 18/038010
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/038010 | Rhodococcus qingshengii bacterial strain that degrades imazethapyr and stimulates crop growth | Nov 14, 2021 | Pending |
Array
(
[id] => 19051173
[patent_doc_number] => 20240093142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => STRAIN FOR DEGRADING DEOXYNIVALENOL AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/254176
[patent_app_country] => US
[patent_app_date] => 2021-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254176
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254176 | STRAIN FOR DEGRADING DEOXYNIVALENOL AND USE THEREOF | Nov 10, 2021 | Pending |
Array
(
[id] => 18900673
[patent_doc_number] => 20240016158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => PLANT DISEASE CONTROL COMPOSITION COMPRISING CULTURE BROTH OF Streptomyces sp. JCK-6141 STRAIN OR EXTRACT OF CULTURE BROTH OF STRAIN, PREPARATION METHOD THEREFOR AND PLANT DISEASE CONTROL METHOD
[patent_app_type] => utility
[patent_app_number] => 18/036743
[patent_app_country] => US
[patent_app_date] => 2021-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036743
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/036743 | PLANT DISEASE CONTROL COMPOSITION COMPRISING CULTURE BROTH OF Streptomyces sp. JCK-6141 STRAIN OR EXTRACT OF CULTURE BROTH OF STRAIN, PREPARATION METHOD THEREFOR AND PLANT DISEASE CONTROL METHOD | Nov 10, 2021 | Pending |
Array
(
[id] => 17428702
[patent_doc_number] => 20220056410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/515985
[patent_app_country] => US
[patent_app_date] => 2021-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17515985
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/515985 | METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES | Oct 31, 2021 | Abandoned |
Array
(
[id] => 19977372
[patent_doc_number] => 12344835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/502259
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 791
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502259
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/502259 | None | Oct 14, 2021 | Issued |
Array
(
[id] => 17368357
[patent_doc_number] => 20220023409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => IMMUNOGENIC COMPOSITION, USE AND METHOD OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/499004
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499004
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499004 | IMMUNOGENIC COMPOSITION, USE AND METHOD OF TREATMENT | Oct 11, 2021 | Abandoned |
Array
(
[id] => 17830114
[patent_doc_number] => 20220267418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/497157
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497157 | ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF | Oct 7, 2021 | Abandoned |